Comparison of the pharmacology of nafarelin and danazol

R L Barbieri, Robert L. Barbieri
American Journal of Obstetrics and Gynecology · 1990 · vol. 162(2) , pp. 581–585 · doi:10.1016/0002-9378(90)90436-b · PMID:2137975 · W2020927789
review OA: closed CC0 ⤵ 13 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper compared the pharmacological effects of nafarelin and danazol, focusing on their mechanisms of action and potential therapeutic applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Danazol Gonadotropin-Releasing Hormone Pregnadienes Animals Danazol Danazol Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Hypothalamo-Hypophyseal System Hypothalamo-Hypophyseal System Nafarelin Ovary Ovary Pregnadienes Receptors, Steroid Receptors, Steroid Sex Hormone-Binding Globulin

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (13)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:12:10.587122+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK